Blackstone Life Sciences V Access Fund, L.P. is a private equity fund based in New York, New York. According to its most recent Form D, filed Sep 18, 2020, it has sold $383,868,991 of interests to 1,883 investors since its first sale in Jul 2020. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Maples Fiduciary Services (Delaware) Inc; iCapital Alternative Investments LLC; Edward Truitt, Jr.
- Total raised
- $383,868,991Cumulative sales reported on Form D
- Investors
- 1,883
- First sale
- Jul 6, 2020
- Minimum investment
- $100,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Maples Fiduciary Services (Delaware) Inc; iCapital Alternative Investments LLC; Edward Truitt, Jr
- Latest Form D
- Sep 18, 2020
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Sep 18, 2020 | Form D/A (amendment) | $383,868,991 | 1,883 | SEC.gov ↗ |
| Jul 10, 2020 | Form D | $0 | 1,883 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jul 10, 2020. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about Blackstone Life Sciences V Access Fund, L.P.
What is the minimum investment for Blackstone Life Sciences V Access Fund, L.P.?
According to its latest Form D, filed Sep 18, 2020, the minimum investment Blackstone Life Sciences V Access Fund, L.P. accepts from an outside investor is $100,000.
Who can invest in Blackstone Life Sciences V Access Fund, L.P.?
Blackstone Life Sciences V Access Fund, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Blackstone Life Sciences V Access Fund, L.P. raised?
Blackstone Life Sciences V Access Fund, L.P. reports $383,868,991 sold from 1,883 investors on its Form D filed Sep 18, 2020. This is cumulative sales since the offering began, not current assets or performance.
Where is Blackstone Life Sciences V Access Fund, L.P. based?
Blackstone Life Sciences V Access Fund, L.P. is based in New York, New York.
When did Blackstone Life Sciences V Access Fund, L.P. launch?
Blackstone Life Sciences V Access Fund, L.P. reports its first sale in Jul 2020.
Size compared with every private equity fund
Raised more than 88% of the 3,661 private equity funds based in New York, and more than 87% of all 8,931 that report sales.
Other funds with the same team
- NB Secondary Opportunities VI Access Fund, L.P.$447M
- Vista Foundation Access Fund V, L.P.$415M
- Blackstone Life Sciences VI Access Fund, L.P.$296M
- Ardian Secondaries Access Fund IX, L.P.$213M
- DSOF Access Fund, L.P.$212M
- OrbiMed Healthcare Access Fund II, L.P.$192M
- HarbourVest Venture XIII Access Fund, L.P.$175M
- LLCP Small Cap Fund IV, L.P.$110M